Advanced Clinical-Grade Wearable Solutions for Digital Research, Decentralized Trials, and Remote Patient Monitoring.
Dongguan Trial Medical Co., Ltd. stands at the vanguard of the digital health revolution. As a specialized manufacturer of remote clinical trial monitoring devices and decentralized clinical trial (DCT) solutions, we have redefined how biometric data is captured, analyzed, and utilized in global healthcare. Established in 2016 and headquartered in Dongguan—the world's epicenter for electronic innovation—we bridge the gap between consumer electronics and high-precision medical diagnostic tools.
Operating from an expansive 11,000 square meter facility with a dedicated team of over 230 specialists, our mission is to provide the "Information Gain" necessary for Pharmaceutical companies and Clinical Research Organizations (CROs) to succeed in an increasingly complex regulatory landscape. Our Smartwatch Health Applications are not mere fitness trackers; they are robust data collection hubs designed for 24/7 high-fidelity monitoring.
Moving beyond simple heart rate monitoring, our roadmap includes medical-grade PPG for SpO2, ECG for arrhythmia detection, and non-invasive blood glucose trend analysis using AI-enhanced spectral algorithms.
Implementing on-device machine learning models that can identify "Patient Distress Events" in real-time without needing constant cloud synchronization, reducing latency and enhancing patient safety.
The future of health data is privacy. We are integrating blockchain-based data ledger systems and hardware-level encryption to ensure that every byte of patient data is immutable and secure.
Our solutions are engineered to solve the most pressing challenges in the modern clinical landscape. We provide End-to-End Decentralized Trial Support, allowing patients to participate in life-saving research from the comfort of their homes. This increases participant diversity, improves retention rates, and significantly lowers the cost of Phase II and Phase III trials.
Streamline drug efficacy monitoring through continuous biometric tracking and electronic Clinical Outcome Assessments (eCOA).
Specialized smartwatch interfaces for the elderly, including fall detection, medication reminders, and direct emergency VoIP links.
Mass-scale monitoring tools for government health agencies to track epidemic trends through localized biometric heatmaps.
Located in the heart of Dongguan, Trial Medical leverages the "China Factory 4.0" philosophy. We have integrated smart ERP and MES systems that provide real-time visibility into every stage of production. This ensures that our OEM and ODM services are not only scalable but highly resilient to global supply chain fluctuations.
Navigating the regulatory waters of health tech requires deep expertise. We provide comprehensive support for FDA, CE (MDR), and HIPAA compliance. Our software ecosystem is built with GDPR principles at its core, ensuring that whether your trial is in North America, Europe, or the Asia-Pacific, your data management meets the highest local standards.
We provide full Technical Files and Quality Management System (QMS) documentation to assist our clients with their own certifications.
Our applications support over 40 languages, ensuring participants from Latin America to Africa have a seamless user experience.
Data residency is key. We offer cloud hosting solutions that keep sensitive health data within the patient's home country.
Our sensors undergo rigorous validation against gold-standard clinical equipment. We achieve over 98% correlation with hospital-grade ECG and pulse oximetry monitors.
Yes. We provide robust APIs and SDKs (iOS/Android) that allow seamless data flow into major Electronic Case Report Form (eCRF) and EHR systems via HL7 FHIR standards.
Standard prototyping takes 4-6 weeks, with full-scale medical production ready within 12-16 weeks depending on regulatory requirements.
We use ultra-low-power Bluetooth (BLE 5.2) and custom power management ICs to ensure 7-14 days of continuous biometric data collection on a single charge.